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Background
Cancer of the urinary bladder is a common malignant
disease in Poland. Molecular genetic alterations play a
key role in bladder cancer carcinogenesis. Understand-
ing genetic events that lead to initiation and progression
of bladder cancer remains an important challenge in
urological research.
Materials and methods
44 lesions were determined to be non-invasive tumors
(pTa), whereas 36 tumors were invasive (pT1-T4).
Tumor grade was noted low (G1) in 46 cases and high
(G2-3) in 34 cases. DNA samples were evaluated for
CDKN2A mutations with the use of MSSCP and
sequencing method.
Results
We found common polymorphic variants reported in
the literature at codon 148 in exon 2 (Arg148Thr) and
at nucleotides 500 and 540 in the 3’untranslated region
which were not considered to be functional variants.
We compared the obtained frequencies for the particu-
lar CDKN2A variants with the control group for the
Polish population examined by Debniak and colleagues
(Cancer Research 2005) and we found a significant dif-
ference in A148T polymorphism occurrence in the
group of the bladder cancer patients (G test, table 2
×2: NBLADDER CANCER =80, NCONTROL=1210, G=10.214,
p<0.01). The Nt 500c>g, Nt540c>t polymorphisms
recorded in the group of the bladder cancer patients in
our study is not different from those recorded in the
control group.
Conclusion
The A148T variant of CDKN2A gene seems to be asso-
ciated with an increased risk of bladder cancer
development.
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